Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty (NCT05845021)
The Impact of a Surgeon-Initiated Bone Health Referral Pathway on Implant-Related Complications in Patients With Osteoporosis Undergoing Lower Extremity Arthroplasty
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to observe the impact of a surgeon-driven bone health referral pathway following lower extremity arthroplasty. The main question this study aims to answer is: 1\) What is impact of a surgeon-driven bone health referral pathway on implant-related complications and fragility fractures when compared to standard of care primary care provider referral. Researchers will compare the endocrinology referral pathway and standard of care to see if there is a difference in treatment rates, fragility fractures, and implant-related complications following lower extremity arthroplasty.
Who can join: Review the eligibility criteria below.
Location: Charter Professional Center — Columbia, Maryland
Age range: 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Charter Professional Center — Columbia, Maryland
📞 Contact the Study Coordinator
Phone: (443) 997-2663
Email: sthakka2@jhmi.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Osteoporosis
- Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of Life — Englewood, Colorado
- Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis — Toronto, Ontario
- A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis — Basking Ridge, New Jersey
- Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI — West Orange, New Jersey
- Teriparatide (PTH) and Bone Strength in Postmenopausal Women — Toronto, Ontario
- Closing The Post Fracture Care Gap In Manitoba — Winnipeg, Manitoba
Explore by condition: All Osteoporosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.